History of COVID-19 increases risk of fatigue and other long COVID symptoms in adults and children

United Kingdom News News

History of COVID-19 increases risk of fatigue and other long COVID symptoms in adults and children
United Kingdom Latest News,United Kingdom Headlines
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 74 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 33%
  • Publisher: 71%

History of COVID-19 increases risk of fatigue and other long COVID symptoms in adults and children Children Coronavirus Disease COVID Fatigue medrxivpreprint WeillCornell CDCgov LPHIorg harvardmed

By Dr. Priyom Bose, Ph.D.Dec 21 2022Reviewed by Benedette Cuffari, M.Sc. Many individuals who have recovered from acute infection with the severe acute respiratory syndrome coronavirus 2 develop persistent symptoms collectively referred to as post-acute sequelae of the coronavirus disease 2019 or long COVID. Some common long COVID symptoms include fatigue, cognitive impairment, diabetes, shortness of breath, mental health conditions, cardiovascular diseases, and adverse kidney conditions.

More research is required to better understand new symptoms and conditions after recovery from SARS-CoV-2 infection. Most studies related to PASC have focused on specific patient populations, such as Medicare patients or United States veterans. Other studies that targeted the general adult population did not have a well-defined control group, thus minimizing the significance of these studies.

Relevant patient data was acquired from PCORnet between March 1, 2020, and May 31, 2020. A total of 3,091,580 adults above 20 years of age and 675,643 children younger than 19 years of age, who met all inclusion criteria, were included in this study. About 88% of the patients in this study were male and were relatively older, with a mean age of 59 years.

A significant difference in the prevalence of symptoms and incidence of conditions following COVID-19 was found between hospitalized and non-hospitalized groups. After adjusting for confounding factors, the hospitalized group with severe SARS-CoV-2 infection was at an increased risk of developing type 1 or 2 diabetes, hematologic disorders, and respiratory diseases. Notably, these outcomes were not observed among hospitalized patients who were negative for COVID-19.

An increased prevalence of certain conditions was reported among hospitalized adults who were negative for COVID-19, including major cardiovascular events, neurologic disorders, and mental health conditions.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Review on nanoparticles usage for treating thrombosis induced by SARS-CoV-2 infectionsReview on nanoparticles usage for treating thrombosis induced by SARS-CoV-2 infectionsReview on nanoparticles usage for treating thrombosis induced by SARS-CoV-2 infections MonashUni Nanoparticles Thrombosis COVID19 SARSCoV2
Read more »

What are the long-term outcomes of critical COVID-19 patients?What are the long-term outcomes of critical COVID-19 patients?What are the long-term outcomes of critical COVID-19 patients? MonashUni COVID19 SARSCoV2 LongTermOutcome
Read more »

South Korean parents' attitudes and perceptions towards child COVID-19 vaccinationSouth Korean parents' attitudes and perceptions towards child COVID-19 vaccinationSouth Korean parents' attitudes and perceptions towards child COVID-19 vaccination Children Coronavirus Disease COVID Vaccine JAMANetworkOpen SNUnow covid19korea
Read more »

Study finds increased risk of POTS after SARS-CoV-2 infection or COVID vaccinationStudy finds increased risk of POTS after SARS-CoV-2 infection or COVID vaccinationStudy finds increased risk of POTS after SARS-CoV-2 infection or COVID vaccination Coronavirus Disease COVID SARSCoV2 tachycardia NatureCVR karolinskainst UBuffalo
Read more »

Can ivermectin improve the duration of sustained recovery among COVID-19 outpatients?Can ivermectin improve the duration of sustained recovery among COVID-19 outpatients?Can ivermectin improve the duration of sustained recovery among COVID-19 outpatients? DukeMedSchool medrxivpreprint Ivermectin COVID19 SARSCoV2 SustainedRecovery
Read more »



Render Time: 2025-02-20 23:03:37